KeyCorp Estimates Corteva's FY2027 Earnings (NYSE:CTVA)

Key Points

• KeyCorp maintained an Overweight rating on Corteva and set a $17 price target, forecasting EPS of $1.15 for FY2027 and $1.30 for FY2028. The broader analyst consensus remains “Moderate Buy,” with a $64 average price target.
• Corteva’s shares were reported down 5.5%, opening at $13.66, despite the company beating quarterly EPS estimates with $2.30 per share. Revenue of $6.38 billion fell short of expectations and declined 1.2% year over year.
• The company paid a quarterly dividend of $0.18, equivalent to $0.72 annually and a reported 5.3% yield; institutional investors own 81.54% of Corteva’s stock.

Corteva, Inc. (NYSE:CTVA - Free Report) - Stock analysts at KeyCorp issued their FY2027 earnings per share (EPS) estimates for shares of Corteva in a report issued on Wednesday, October 7th. KeyCorp analyst S. Tiano forecasts that the company will earn $1.15 per share for the year. KeyCorp has a "Overweight" rating and a $17.00 price objective on the stock. The consensus estimate for Corteva's current full-year earnings is $1.69 per share. KeyCorp also issued estimates for Corteva's FY2028 earnings at $1.30 EPS.

Several other equities analysts have also recently issued reports on CTVA. Barclays upped their price target on shares of Corteva from $84.00 to $91.00 and gave the company an "overweight" rating in a research report on Thursday, June 11th. Royal Bank Of Canada reiterated an "outperform" rating and set a $17.00 price target on shares of Corteva in a report on Wednesday. New Street Research set a $17.00 price objective on shares of Corteva in a research note on Monday. UBS Group increased their price objective on Corteva from $85.00 to $90.00 and gave the company a "neutral" rating in a report on Wednesday, September 16th. Finally, Weiss Ratings downgraded Corteva from a "hold (c+)" rating to a "hold (c)" rating in a report on Monday, August 3rd. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, Corteva currently has a consensus rating of "Moderate Buy" and a consensus price target of $64.00.

Corteva Stock Down 5.5%

NYSE:CTVA opened at $13.66 on Friday. Corteva has a one year low of $11.74 and a one year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The company has a market cap of $9.12 billion, a PE ratio of 9.05, a P/E/G ratio of 1.25 and a beta of 0.57. The firm's 50 day simple moving average is $72.79 and its 200 day simple moving average is $78.74.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating analysts' consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same period last year, the firm posted $2.20 earnings per share. The business's revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS.

Hedge Funds Weigh In On Corteva

Several hedge funds have recently modified their holdings of CTVA. BlackRock Inc. bought a new stake in Corteva during the second quarter worth $4,560,180,000. Wellington Management Group LLP boosted its position in Corteva by 941.7% in the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company's stock worth $644,720,000 after purchasing an additional 6,881,875 shares during the last quarter. Jupiter Topco LLC bought a new position in Corteva in the 2nd quarter valued at $544,246,000. Bank of America Corp DE purchased a new stake in shares of Corteva during the 2nd quarter valued at $484,927,000. Finally, Legal & General Group Plc purchased a new stake in shares of Corteva during the 2nd quarter valued at $482,836,000. Institutional investors own 81.54% of the company's stock.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 5.3%. The ex-dividend date of this dividend was Tuesday, September 1st. Corteva's dividend payout ratio is presently 47.68%.

Corteva News Roundup

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: KeyBanc upgraded Corteva to Overweight after the Vylor separation and set a $17 price target. The firm expects the streamlined company could achieve “meaningful” earnings growth after 2027, potentially supporting a re-rating of the shares. Corteva upgraded at KeyBanc after spinoff of Vylor
• Positive Sentiment: Options activity was unusually bullish, with investors purchasing 5,408 call options—more than five times typical daily volume. This indicates increased speculative interest in a potential recovery, although options activity is not a guarantee of future performance.
• Positive Sentiment: Commentator Jim Cramer said he would be comfortable building a position in Vylor, the spun-off seed business, suggesting the separation may make the higher-quality growth assets more attractive to investors. However, he remained cautious on Corteva’s crop-protection operations. Jim Cramer Sees One Stock to Own After Corteva’s Breakup
• Neutral Sentiment: KeyCorp maintained an Overweight rating and a $17 target, but its analyst projected only $1.60 in FY2029 EPS. That estimate is below the current-year consensus of $2.77, highlighting uncertainty over the pace and durability of post-spinoff earnings growth.
• Negative Sentiment: Zacks Research downgraded Corteva from Hold to Strong Sell, creating a significant counterweight to the KeyBanc upgrade and likely contributing to investor caution. Corteva Downgraded by Zacks Research

Corteva Company Profile

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.